Importance of miR-20a expression in prostate cancer tissue

Anticancer Research

Volumn 30, Issue 9, 2010, Pages 3579-3583

  Pesta, M ^a   Klecka, J ^a   Kulda, V ^a   Topolcan, O ^a   Hora, M ^a   Eret, V ^a   Ludvikova, M ^a   Babjuk, M ^b   Novak, K ^b   Stolz, J ^b   Holubec, Lubos ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

let 7a; miR 15a; miR 16; miR 20a; miRNA; Prostate cancer

Indexed keywords

MICRORNA; MICRORNA 15A; MICRORNA 16; MICRORNA 20A; MICRORNA LET 7A; UNCLASSIFIED DRUG; UNTRANSLATED RNA; MIRN20 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL DIFFERENTIATION; CLINICAL FEATURE; GENE EXPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENETICS; MALE; MIDDLE AGED; PROSTATE TUMOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 77958567958     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics 2009. CA Cancer J Clin 59(4): 225-249, 2009.
2. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6(4): 259-269, 2006.
3. Sassen S, Miska EA and Caldas C: MicroRNA: implications for cancer. Virchows Arch 452(1): 1-10, 2008.
4. Visone R and Croce CM: MiRNAs and cancer. Am J Pathol 174(4): 1131-1138, 2009.
5. Mirnezami AH, Pickard K, Zhang L, Primrose JN and Packham G: MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol 35(4): 339-347, 2009.
6. Chan SH, Wu CW, Li AF, Chi CW and Lin WC: miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 28(2A): 907-911, 2008.
7. Croce CM: Oncogenes and cancer. N Engl J Med 358(5): 502-511, 2008.
8. Carthew RW and Sontheimer EJ: Origins and mechanisms of miRNAs and siRNAs. Cell 136(4): 642-655, 2009.
9. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G: The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403(6772): 901-906, 2000. (Pubitemid 30130993)
10. Roush S and Slack FJ: The let-7 family of microRNAs. Trends Cell Biol 18(10): 505-516, 2008.
11. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential human oncogene. Nature 435(7043): 828-833, 2005.
12. + cells. Blood 109(10): 4399-4405, 2007.
13. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and Takahashi T: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65(21): 9628-9632, 2005.
14. Eiriksdottir G, Johannesdottir G, Ingvarsson S, Björnsdottir IB, Jonasson JG, Agnarsson BA, Hallgrimsson J, Gudmundsson J, Egilsson V, Sigurdsson H and Barkardottir RB: Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur J Cancer 34(13): 2076-2081, 1998.
15. Lin YW, Sheu JC, Liu LY, Chen CH, Lee HS, Huang GT, Wang JT, Lee PH and Lu FJ: Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur J Cancer 35(12): 1730-1734, 1999.
16. Shao J, Li Y, Wu Q, Liang X, Yu X, Huang L, Hou J, Huang X, Ernberg I, Hu LF and Zeng Y: High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China. Chin Med J (Engl) 115(4): 571-575, 2002.
17. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F and Croce CM: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99(24): 15524-15529, 2002.
18. Poliseno L, Pitto L, Simili M, Mariani L, Riccardi L, Ciucci A, Rizzo M, Evangelista M, Mercatanti A, Pandolfi PP and Rainaldi G: The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence. PLoS One 3(7): e2542, 2008.
19. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, Alder H, Volinia S, Rassenti L, Liu X, Liu CG, Kipps TJ, Negrini M and Croce CM: MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 105(13): 5166-5171, 2008.
20. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL and Visakorpi T: MicroRNA expression profiling in prostate cancer. Cancer Res 67(13): 6130-6135, 2007. (Pubitemid 47037493)
21. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G and Chartrand P: An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282(4): 2135-2143, 2007.
22. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC and Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103(7): 2257-2261, 2006.
23. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C and De Maria R: The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14(11): 1271-1277, 2008.
24. Choong ML, Yang HH and McNiece I: MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp Hematol 35(4): 551-564, 2007.
25. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W and Nikitin AY: MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67(18): 8433-8438, 2007.
26. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS and Sung JJ: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58(10): 1375-1381, 2009.
27. Peters IR, Helps CR, Calvert EL, Hall EJ and Day MJ: Cytokine mRNA quantification in duodenal mucosa from dogs with chronic enteropathies by real-time reverse transcriptase polymerase chain reaction. J Vet Intern Med 19(5): 644-653, 2005. (Pubitemid 41452334)
28. Stamey TA, McNeal JE, Yemoto CM, Sigal BM and Johnstone IM: Biological determinants of cancer progression in men with prostate cancer. JAMA 281(15): 1395-1400, 1999.
29. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack FJ: RAS is regulated by the let-7 microRNA family. Cell 120(5): 635-647, 2005.